PET Systems

GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. 

New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were deemed unnecessary. 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET/CT, webinar, photon counting

The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and quantitative accuracy, explain improvements in image q...

 Loyola University Medical Center is now offering patients the most advanced positron emission tomography/computed tomography (PET/CT) scanner on the...
April 11, 2014 — A University of Colorado Cancer Center study presented at the 2014 annual meeting of the American Association for Cancer Research (AACR)...
GE Healthcare Q.Clear Technology PET/CT Systems Nuclear Imaging
GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times...
Pre-operative PET Lung Surgeries Nuclear Imaging Clinical Study
New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
Based on Philips’ proprietary digital photon counting technology, the Vereos PET/CT is the first PET/CT system in the industry to use...
The U.S. Food and Drug Administration (FDA) designated the Society of Nuclear Medicine and Molecular Imaging's (SNMMI's) ...
Vizamyl (flutemetamol F 18 injection) is a radiopharmaceutical tracer for use with positron emission tomography (PET) imaging of...

Articles

GE Healthcare Q.Clear Technology PET/CT Systems Nuclear Imaging
GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times...
Pre-operative PET Lung Surgeries Nuclear Imaging Clinical Study
New quantitative data suggests that 30 percent of the surgeries performed for non-small cell lung cancer patients in a community-wide clinical study were...
Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's
The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify...
What was once diagnostic imaging is on track to becoming much more. Radiology is on the verge of a new era in which its focus goes beyond the traditional...

Video Center

The 24th Annual Interdisciplinary Breast Center Conference (NCoBC 2014), sponsored by the National...
3 weeks 6 days ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
5 weeks 20 hours ago
Vienna is to the European Congress of Radiology what Chicago is to RSNA. This year the ECR...
5 weeks 5 days ago
This webinar will allow clinicians to learn more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and technologies include...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
Lydia Liao spectral mammography
During this webinar, Lydia Liao,  M.D., Ph.D., M.P.H., presented an overview of contrast-enhanced spectral mammography technology and shared cases where SenoBright has...

Comparison Charts

Sorry there is no data available